What is the recommended evaluation and management for a 50-year-old man with fatigue, elevated ferritin, and a 4 cm × 6 cm subcapsular hypoechoic lesion in the posterior left hepatic lobe?

Evaluation and Management of a 50-Year-Old Man with Elevated Ferritin, Fatigue, and a 4×6 cm Hepatic Lesion

Immediate Diagnostic Priority: Characterize the Liver Lesion First

Order MRI of the abdomen with and without IV contrast immediately to definitively characterize this 4×6 cm subcapsular hypoechoic lesion, as MRI establishes a diagnosis in 95% of liver lesions and is the preferred modality for indeterminate hepatic masses. 1, 2

Why MRI is Essential in This Case

• The American College of Radiology rates MRI abdomen with contrast as 6 out of 9 (appropriate) for chronic liver disease assessment, superior to CT's rating of 5 out of 9 3
• MRI with gadolinium differentiates between common benign lesions in 70% of cases and establishes definitive diagnosis in 95% of liver lesions, compared to only 74-95% with CT 3, 1
• Only 1.5% of patients require additional imaging after MRI versus 10% after CT 2
• For this 4×6 cm lesion in a subcapsular location, MRI with hepatobiliary contrast can simultaneously assess for fibrosis using MR elastography 3

Alternative if MRI is Contraindicated

• If MRI cannot be performed, order triphasic contrast-enhanced CT (arterial, portal venous, and delayed phases) with 2.5-5 mm slice thickness 3, 1, 2
• Triphasic CT has 95.5% diagnostic accuracy compared to single-phase CT's 74-95% accuracy 3
• Critical pitfall to avoid: Do not order CT with and without contrast, as the unenhanced phase adds no diagnostic value and doubles radiation exposure 3

Concurrent Iron Workup: Assess for Hemochromatosis

While awaiting imaging, immediately measure transferrin saturation (TSAT), complete iron panel, and HFE genetic testing to evaluate for hereditary hemochromatosis, as this 50-year-old male with fatigue and elevated ferritin fits the classic presentation. 4

Diagnostic Thresholds for Hemochromatosis

• In males, provisional iron overload is defined as TSAT >50% and ferritin >300 µg/L 4
• If TSAT >60%, there is 95.3% probability of severe hepatic iron overload (liver iron concentration >7 mg/g) 5
• If TSAT <60% but ferritin >963 µg/L, this also predicts grade 3 hepatic iron overload with 95% accuracy 5

HFE Genotyping Strategy

• Test for p.C282Y homozygosity, as this is by far the most common genetic cause of hemochromatosis 4
• In p.C282Y homozygotes with elevated TSAT and hyperferritinemia, the diagnosis of hemochromatosis is confirmed without requiring liver biopsy 4
• Testing for p.H63D variant is not necessary for diagnosis, according to EASL guidelines 4

Hepatic Iron Quantification: When to Order MRI R2*

If TSAT and ferritin suggest iron overload but HFE genotyping is negative or shows compound heterozygosity, order hepatic MRI R2 quantification to measure liver iron concentration and guide phlebotomy decisions.* 4, 6

Specific Indications for Iron Quantification MRI

• Patients with unclear cause of hyperferritinemia and biochemical iron overload (elevated TSAT and ferritin) 4
• Patients with positive liver iron staining on any prior biopsy 4
• MRI R2* sequences are the best validated method for non-invasive hepatic iron quantification 4, 6
• Hepatic MRI R2* acts as a surrogate of total body iron stores and predicts the number of phlebotomies required 4

When Iron MRI is NOT Required

• In p.C282Y homozygotes with elevated TSAT and hyperferritinemia without additional risk factors, iron quantification MRI is not required for diagnosis, though it can determine degree of overload 4
• If TSAT and ferritin thresholds above (TSAT >60% or ferritin >963 µg/L with TSAT <60%) are met, severe iron overload is already established 5

Critical Assessment: Rule Out Hepatocellular Carcinoma

Measure serum alpha-fetoprotein (AFP) immediately, as untreated hemochromatosis can progress to cirrhosis and hepatocellular carcinoma (HCC), and this 4×6 cm lesion requires malignancy exclusion. 4, 2

HCC Risk Stratification

• If AFP is elevated and the lesion is >2 cm in a patient with cirrhosis or advanced fibrosis, there is >95% probability of HCC 1, 2
• Hemochromatosis can result in liver fibrosis, cirrhosis, and HCC if untreated 4
• Patients with advanced fibrosis must be included in HCC screening programs 4

Lesion-Specific Considerations

• This 4×6 cm subcapsular hypoechoic lesion could represent multiple entities: hemangioma, focal nodular hyperplasia, hepatocellular adenoma, HCC, or even rare entities like epithelioid hemangioendothelioma 1, 7
• Subcapsular location is seen in 85% of hepatic epithelioid hemangioendotheliomas, which present as hypoechoic lesions with mean size 4.2 cm 7
• Do not assume this lesion is benign based on size alone—a 4×6 cm lesion requires definitive imaging characterization regardless of symptoms 2

Fibrosis Assessment: Determine Disease Stage

Once the lesion is characterized, assess liver fibrosis stage using either MR elastography (performed simultaneously with diagnostic MRI) or non-invasive serum markers, as fibrosis stage determines management intensity. 4, 3

Why Fibrosis Staging Matters

• Stage of liver fibrosis determines disease management and surveillance requirements 4
• Patients with advanced fibrosis require HCC screening every 6 months 4
• In patients with excessive alcohol consumption and elevated iron parameters, risk of fibrosis and hepatocellular malignancy is significantly increased 4

Methods for Fibrosis Assessment

• MRI with MR elastography can assess cirrhosis and perform elastography simultaneously 3
• Ultrasound with acoustic radiation force impulse (ARFI) elastography is an alternative 3
• MR elastography is superior to CT for cirrhosis evaluation 3

Treatment Algorithm: Phlebotomy for Iron Overload

If hemochromatosis is confirmed, initiate therapeutic phlebotomy immediately with target ferritin <50 µg/L during induction phase and <100 µg/L during maintenance phase to prevent progression to cirrhosis and HCC. 4

Phlebotomy Protocol

• Early diagnosis and treatment by phlebotomy can prevent cirrhosis, HCC, diabetes, and arthropathy 4
• Mild signs of iron overload (increased serum ferritin) benefit from phlebotomy 4
• Between 14-30% of patients referred for phlebotomy are compound heterozygotes, so phlebotomy is appropriate even in non-C282Y homozygotes with confirmed iron overload 4

Additional Risk Factor Management

• Management of additional environmental risk factors or associated liver diseases is crucial 4
• Weight loss through dietary modification and increased physical activity should be recommended if fatty liver disease is present 4
• Counsel on alcohol avoidance, as alcohol increases risk of fibrosis and HCC in iron overload 4

Cardiac Assessment in Severe Cases

If hepatic iron concentration is markedly elevated (>7 mg/g) or if there are any signs of heart disease, order cardiac MRI T2 to assess for cardiac iron deposition, as cardiac involvement significantly impacts mortality.* 4

• Cardiac MRI should be performed in patients with hemochromatosis and signs of heart disease 4
• Severe or early-onset hemochromatosis can be associated with heart failure 4
• Cardiac T2* mapping is suitable for assessment of cardiac iron 6

Common Pitfalls to Avoid

• Do not order liver biopsy for this lesion before obtaining diagnostic MRI or CT, as biopsy carries 9-12% bleeding risk and 30% false-negative rate for small lesions 2
• Do not order single-phase contrast CT—if using CT, always obtain triphasic imaging 3
• Do not order Tc-99m sulfur colloid scan, as it has no role in modern evaluation of liver lesions 1, 2
• Do not delay phlebotomy once hemochromatosis is confirmed, as untreated disease progresses to irreversible complications 4
• Do not assume normal AFP excludes malignancy, but low AFP supports benign etiology 2